Eurofins Scientific SE/ FR0014000MR3 /
2024-03-28 11:08:34 AM | Chg. +0.70 | Volume | Bid2024-03-28 | Ask11:08:43 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
57.98EUR | +1.22% | 31,928 Turnover: 781,252.93 |
57.96Bid Size: 47 | 58.00Ask Size: 98 | 11.26 bill.EUR | 0.86% | 19.72 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 2.96 EUR | -17.09% |
EPS Diluted: | - EUR | -16.52% |
Revenues per Share: | 33.77 EUR | -3.14% |
Book Value per Share: | 26.32 EUR | 5.96% |
Cash Flow per Share: | 5.28 EUR | -10.61% |
Dividend per Share: | 0.50 EUR | -50.00% |
Total | in mill. | |
Revenues: | 6,514.60 EUR | -2.94% |
Net Income: | 570.20 EUR | -17.05% |
Operating Cash Flow: | 1,017.90 EUR | - |
Cash and Cash Equivalents: | 1,221.20 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 19.72 | 19.93 |
P/S Ratio: | 1.73 | 1.75 |
P/BV ratio: | 2.22 | 2.24 |
P/CF Ratio: | 11.06 | 11.18 |
PEG: | -1.15 | -1.17 |
Earnings Yield: | 5.07% | 5.02% |
Dividend Yield: | 0.86% | 0.85% |
Market Capitalization | ||
Market Capitalization: | 11.26 bill. EUR | 11.38 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | 182,168.4197 EUR | 184,103.7250 EUR |
Shares Outstanding: | 192.9 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | 12.92% |
Net Profit Margin: | 8.75% |
Return on Equity: | 11.23% |
Return on Assets: | 5.24% |
Financial Strength
Liquidity I / Cash Ratio: | 57.56% |
Liquidity II / Quick Ratio: | 108.12% |
Liquidity III / Current Ratio: | 144.53% |
Debt / Equity Ratio: | 114.45% |
Dynam. Debt / Equity Ratio: | 570.89% |
Efficiency
Employees: | 61,798 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 105,417.65 EUR |
Net Income / Employee: | 9,226.84 EUR |
Total Assets / Employee: | 176,196.64 EUR |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |